An assessment of effect of pre operative Proluton in patients with operable breast cancer
Phase 2
- Conditions
- Health Condition 1: null- Operable Breast Cancer
- Registration Number
- CTRI/2014/11/005229
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Breast cancer patients with loco-regionally confined disease planned for up front surgery shall be taken into the study. FNAC or core biopsy proven breast cancer with clinically positive axillary nodes T1-3 N1 patients will be eligible
Exclusion Criteria
1.Prior excision biopsy
2.Patients receiving preoperative chemotherapy
3.Prior treatment for any other malignancies
4.Women who are pregnant, breast-feeding.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method